New study aims to unlock secrets of breast cancer treatment resistance
NCT ID NCT06361940
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study looks at why some hormone receptor-positive breast cancers become resistant to standard hormone-blocking therapy. About 100 women with early-stage breast cancer will receive anti-estrogen treatment for 4-12 weeks before surgery. Researchers will analyze tumor samples to find molecular changes that predict resistance, with the goal of personalizing future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Froedtert Hospital and the Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.